Liquidia Corporation $LQDA Shares Sold by JW Asset Management LLC

JW Asset Management LLC reduced its position in Liquidia Corporation (NASDAQ:LQDA) by 9.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 99,776 shares of the company’s stock after selling 10,224 shares during the period. Liquidia makes up approximately 1.1% of JW Asset Management LLC’s holdings, making the stock its 12th largest holding. JW Asset Management LLC’s holdings in Liquidia were worth $3,441,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Covestor Ltd lifted its stake in shares of Liquidia by 41.9% in the 4th quarter. Covestor Ltd now owns 1,216 shares of the company’s stock valued at $42,000 after purchasing an additional 359 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of Liquidia by 7.2% in the 4th quarter. PNC Financial Services Group Inc. now owns 6,304 shares of the company’s stock valued at $217,000 after purchasing an additional 422 shares in the last quarter. ProShare Advisors LLC lifted its stake in shares of Liquidia by 7.1% in the 4th quarter. ProShare Advisors LLC now owns 11,756 shares of the company’s stock valued at $405,000 after purchasing an additional 775 shares in the last quarter. Alliancebernstein L.P. lifted its stake in shares of Liquidia by 1.4% in the 3rd quarter. Alliancebernstein L.P. now owns 67,050 shares of the company’s stock valued at $1,525,000 after purchasing an additional 900 shares in the last quarter. Finally, Skandinaviska Enskilda Banken AB publ acquired a new position in shares of Liquidia in the 3rd quarter valued at about $30,000. 64.54% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other Liquidia news, CFO Michael Kaseta sold 139,390 shares of the company’s stock in a transaction that occurred on Wednesday, April 15th. The stock was sold at an average price of $40.14, for a total value of $5,595,114.60. Following the transaction, the chief financial officer directly owned 353,356 shares of the company’s stock, valued at $14,183,709.84. This represents a 28.29% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Roger Jeffs sold 32,744 shares of the company’s stock in a transaction that occurred on Monday, April 13th. The shares were sold at an average price of $38.37, for a total value of $1,256,387.28. Following the completion of the transaction, the chief executive officer directly owned 1,137,599 shares in the company, valued at approximately $43,649,673.63. The trade was a 2.80% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last ninety days, insiders have sold 1,047,713 shares of company stock valued at $46,156,003. Corporate insiders own 25.60% of the company’s stock.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the company. Needham & Company LLC lifted their price objective on Liquidia from $54.00 to $70.00 and gave the company a “buy” rating in a research note on Monday, May 11th. Wall Street Zen raised Liquidia from a “buy” rating to a “strong-buy” rating in a research note on Saturday, May 16th. Zacks Research raised Liquidia from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, May 5th. Weiss Ratings reissued a “sell (d-)” rating on shares of Liquidia in a research report on Tuesday, April 21st. Finally, Lifesci Capital raised Liquidia to a “strong-buy” rating in a research report on Thursday, March 5th. Three investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating and two have given a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $49.33.

Liquidia Stock Performance

Liquidia stock opened at $61.97 on Friday. The stock’s 50 day moving average price is $41.61 and its 200 day moving average price is $37.08. The firm has a market capitalization of $5.51 billion, a PE ratio of 442.67 and a beta of 0.41. The company has a debt-to-equity ratio of 1.18, a quick ratio of 2.03 and a current ratio of 2.22. Liquidia Corporation has a one year low of $11.85 and a one year high of $62.30.

Liquidia (NASDAQ:LQDA) last released its quarterly earnings results on Monday, May 11th. The company reported $0.52 EPS for the quarter, topping the consensus estimate of $0.41 by $0.11. The firm had revenue of $132.87 million for the quarter, compared to analyst estimates of $119.44 million. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The firm’s revenue for the quarter was up 4187.1% compared to the same quarter last year. As a group, sell-side analysts expect that Liquidia Corporation will post 2.97 EPS for the current fiscal year.

Liquidia Profile

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).